The change of gamma aminobutyric acid A receptor on Parkinsons rat before and after L-dopa treatment
Chinese Journal of Clinical Anatomy ›› 2015, Vol. 33 ›› Issue (6) : 677-680.
The change of gamma aminobutyric acid A receptor on Parkinsons rat before and after L-dopa treatment
Objective To investigate varying pattern of distribution of gamma aminobutyric acid A receptor (GABAAR) before and after treatment in the brain cortex, striatum, substantianigra on Parkinson's disease. Methodes First, the rat model of PD was made, after testing, were randomly divided into treatment group and control group. They were given normal saline and L-dopa methyl ester + Benserazide for 4 weeks. After treatment the behavioral tests were performed. Cerebral cortex, striatum, substantianigra were harvested from rats after treatment of 4, 8, 12 weeks respectively. By immunohistochemistry, the changes in distribution and expression of content of GABAAR in the brain were compared before and after treatment. Results After treatment of 4, 8, 12 weeks immunohistochemical results was subjected through statistical analysis, which showed the content of the brain substantianigra and cortex GABAAR was decreased than before treatment, While the number of striatum showed no changes of GABAAR. Conclusion (1) With treatment of L-dopa methyl ester + Benserazide, the PD symptoms can be improve. (2) The changes of GABAAR are different on different parts of PD rats before and after treatment.
Parkinson's disease / Gamma aminobutyric acid / Gamma aminobutyric acid A receptor
[1] 李小茜，何建成. γ-氨基丁酸与帕金森病、左旋多巴诱发异动症的研究进展[J].医学研究杂志，2013，42（3）:6-8.
[2] 郭燕舞，李明，张世忠. γ-氨基丁酸治疗帕金森病的研究展望［J］.实用医学杂志，2009，25（18）：2991-2993.
[3] 包新民，舒斯云. 大鼠脑立体定位图谱[M]. 北京；人民卫生出版社，1991，12（1）：48-54.
[4] 孟涛，林玲，郑志竑,等.大鼠胚胎中脑腹侧细胞和大脑皮质神经干细胞移植治疗帕金森大鼠的比较[J].神经解剖学杂志，2009，25(5):493-496.
[5] Mochizuki H， Yasuda T， Mouradian MM． Advances in gene therapy for movement disorders [J]. Neurotherapeutics， 2008，5（2）：260-269．
[6] 郭文，王丽.氯巴占耐受听源性惊厥大鼠脑GABAA受体亚单位表达的变化[J]．中国药理学通报，2002,18(2)：183-186.
/
| 〈 |
|
〉 |
